Founders Fund VII Management, LLC

In its 13F for Q1 2024 (holdings as of March 31, 2024, filed May 15, 2024), Founders Fund VII Management, LLC reported 2 stock positions worth $19.4 million. Its top holding was Abcellera Biologics (ABCL) at 88.0% of the portfolio, followed by Compass Pathways (CMPS, 12.0%). Its holdings were unchanged from Q4 2023.

Most Recent 13F
Q4 2025
Location
SAN FRANCISCO, CA
CIK
0001846021
Portfolio Value
$19.4M (Q1 2024)
SEC Filing
0001085146-24-002617 ↗ filed May 15, 2024

Holdings Value

0$5.0M$10.0M$15.0M$20.0M Q1 2024: $19.4M $19.4M Q1 2024 Q2 2024: $12.9M Q2 2024 Q3 2024: $1.8M Q3 2024 Q4 2024: $1.1M Q4 2024 Q1 2025: $798K Q1 2025 Q2 2025: $781K Q2 2025 Q3 2025: $1.7M Q3 2025 Q4 2025: $2.0M Q4 2025

Holdings 2 stocks · $19.4M
ABCL Abcellera Biologics Inc. 88.05% 3,773,530 $17.1M No change
CMPS Compass Pathways PLC 11.95% 278,880 $2.3M No change

Portfolio Sells Q4 2023 → Q1 2024
None this quarter.

Portfolio Buys Q4 2023 → Q1 2024
None this quarter.

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q4 2025 2$2.0MCMPS, RUM
Q3 2025 2$1.7MCMPS, RUM
Q2 2025 1$781KCMPS
Q1 2025 1$798KCMPS
Q4 2024 1$1.1MCMPS
Q3 2024Amended 1$1.8MCMPS
Q2 2024 2$12.9MABCL, CMPS
Q1 2024 2$19.4MABCL, CMPS